Chemours (CC) PT Lowered to $26 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $17.20 -1.55%
Rating Summary:
10 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 11 | New: 5
Rating Summary:
10 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 11 | New: 5
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $26.00 (from $29.00) while maintaining a Outperform rating.
You May Also Be Interested In
- MaxLinear (MXL) PT Raised to $120 at Stifel
- Popular, Inc. (BPOP) PT Raised to $214 at Benchmark
- RTX Corp. (RTX) PT Raised to $215 at UBS, Neutral Rating Maintained Given Premium Valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
